Ascendis Pharma A (ASND) Interest Expense - Deposits (2019 - 2025)

Ascendis Pharma A has reported Interest Expense - Deposits for 7 years, with the latest figure at -$27.0 million in Q2 2025.

• Quarterly Interest Expense - Deposits rose 59.22% year-over-year to -$27.0 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $850.1 million (up 203.61% YoY) and the FY2024 annual result came in at $597.9 million, up 40.95% from the prior year.
• Interest Expense - Deposits eased to -$27.0 million in Q2 2025 per ASND's latest filing, from $544.8 million in the prior quarter.
• Over five years, Interest Expense - Deposits peaked at $846.8 million in Q1 2022 and troughed at -$287.4 million in Q4 2021.
• A 5-year average of $144.6 million and a median of -$39.9 million in 2023 frame the typical range for Interest Expense - Deposits.
• The sharpest annual moves came in 2021 and 2024: Interest Expense - Deposits slumped 262.51% in 2021, then soared 686.6% in 2024.
• Over 5 years, Interest Expense - Deposits stood at -$287.4 million in 2021, then jumped by 37.44% to -$179.8 million in 2022, then soared by 70.61% to -$52.8 million in 2023, then plunged by 33.43% to -$70.5 million in 2024, then soared by 61.66% to -$27.0 million in 2025.
• According to Business Quant data, Interest Expense - Deposits over the past three periods registered -$27.0 million, $544.8 million, and -$70.5 million for Q2 2025, Q1 2025, and Q4 2024 respectively.